[HTML][HTML] JAK-STAT pathway in carcinogenesis: is it relevant to cholangiocarcinoma progression

OV Smirnova, TY Ostroukhova… - World Journal of …, 2007 - ncbi.nlm.nih.gov
The features of JAK-STAT signaling in liver cells are discussed in the current review. The
role of this signaling cascade in carcinogenesis is accentuated. The possible involvement of …

Revisiting STAT3 signalling in cancer: new and unexpected biological functions

H Yu, H Lee, A Herrmann, R Buettner, R Jove - Nature reviews cancer, 2014 - nature.com
Abstract The Janus kinases (JAKs) and signal transducer and activator of transcription
(STAT) proteins, particularly STAT3, are among the most promising new targets for cancer …

[HTML][HTML] Targeting the JAK/STAT pathway in solid tumors

Z Qureshy, DE Johnson, JR Grandis - Journal of cancer metastasis …, 2020 - ncbi.nlm.nih.gov
Aberrant activation of signal transducer and activator of transcription (STAT) proteins is
associated with the development and progression of solid tumors. However, as transcription …

JAK/STAT signal transduction: promising attractive targets for immune, inflammatory and hematopoietic diseases

Q Gao, X Liang, AS Shaikh, J Zang, W Xu… - Current Drug …, 2018 - ingentaconnect.com
Background: JAK/STAT signal pathway, a requisite part in the signaling process of growth
factors and cytokines, has become attractive targets for numerous immune, inflammatory …

RAS/RAF/MEK/ERK, PI3K/PTEN/AKT/mTORC1 and TP53 pathways and regulatory miRs as therapeutic targets in hepatocellular carcinoma

SM Akula, SL Abrams, LS Steelman… - Expert Opinion on …, 2019 - Taylor & Francis
Introduction: Hepatocellular carcinoma (HCC) is a significant problem globally because of
viral infections and the increasing incidence of obesity and fatty liver disease. However, it is …

[HTML][HTML] Mediator kinase phosphorylation of STAT1 S727 promotes growth of neoplasms with JAK-STAT activation

II Nitulescu, SC Meyer, QJ Wen, JD Crispino… - …, 2017 - thelancet.com
Constitutive JAK-STAT signaling drives the proliferation of most myeloproliferative
neoplasms (MPN) and a subset of acute myeloid leukemia (AML), but persistence emerges …

Therapeutic targeting of the Jak/STAT pathway

S Aittomäki, M Pesu - Basic & clinical pharmacology & …, 2014 - Wiley Online Library
Antibodies that block cytokine function provide a powerful therapeutic tool especially for the
treatment of autoimmune diseases. Cytokines are a group of small hydrophilic glycoproteins …

[PDF][PDF] Sorafenib inhibits signal transducer and activator of transcription‐3 signaling in cholangiocarcinoma cells by activating the phosphatase shatterproof 2

BRA Blechacz, RL Smoot, SF Bronk… - …, 2009 - Wiley Online Library
The Janus kinase/signal transducer and activator of transcription (JAK/STAT) pathway is one
of the key signaling cascades in cholangiocarcinoma (CCA) cells, mediating their resistance …

Current status of molecularly targeted therapy for hepatocellular carcinoma: basic science

S Tanaka, S Arii - International journal of clinical oncology, 2010 - Springer
Conventional systemic chemotherapy has been developed with so-called anti-cancer
agents, essentially screened for cytotoxicity to cultured cancer cells. However, in patients …

[HTML][HTML] Targeted blockade of JAK/STAT3 signaling inhibits proliferation, migration and collagen production as well as inducing the apoptosis of hepatic stellate cells

YJ Gu, WY Sun, S Zhang, XR Li… - … journal of molecular …, 2016 - spandidos-publications.com
Protein tyrosine kinases belonging to the Janus kinase (JAK) family are associated with
many cytokine receptors, which, on ligand binding, regulate important cellular functions such …